- Home
- ROIV vs FE Comparison
ROIV vs FE Comparison
Compare ROIV & FE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ROIV | FE |
|---|---|---|
| Founded | 2014 | 1996 |
| Country | United Kingdom | United States |
| Employees | 721 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.7B | 28.1B |
| IPO Year | 2021 | 2005 |
Fundamental Metrics
Financial Performance| Metric | ROIV | FE |
|---|---|---|
| Price | $38.99 | $44.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 14 |
| Target Price | $28.94 | ★ $51.46 |
| AVG Volume (30 Days) | ★ 8.5M | 3.0M |
| Earning Date | 05-28-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 3.80% |
| EPS Growth | N/A | ★ 3.53 |
| EPS | N/A | ★ 0.70 |
| Revenue | $8,260,000.00 | ★ $15,090,000,000.00 |
| Revenue This Year | N/A | $4.34 |
| Revenue Next Year | $744.61 | $3.98 |
| P/E Ratio | ★ N/A | $64.73 |
| Revenue Growth | N/A | ★ 12.01 |
| 52 Week Low | $14.50 | $43.19 |
| 52 Week High | $42.50 | $52.34 |
Technical Indicators
Market Signals| Indicator | ROIV | FE |
|---|---|---|
| Relative Strength Index (RSI) | 55.79 | 33.12 |
| Support Level | $33.15 | $43.98 |
| Resistance Level | $42.50 | $45.42 |
| Average True Range (ATR) | 1.45 | 0.70 |
| MACD | 0.05 | -0.07 |
| Stochastic Oscillator | 60.80 | 1.31 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About FE FirstEnergy Corp.
FirstEnergy is an investor-owned holding company with operations across five mid-Atlantic and Midwestern states. FirstEnergy also owns and operates one of the nation's largest electric transmission systems.